Cargando…
Controllable drug uptake and nongenomic response through estrogen-anchored cyclodextrin drug complex
Breast cancer is a leading killer of women worldwide. Cyclodextrin-based estrogen receptor-targeting drug-delivery systems represent a promising direction in cancer therapy but have rarely been investigated. To seek new targeting therapies for membrane estrogen receptor-positive breast cancer, an es...
Autores principales: | Yin, Juan-Juan, Shumyak, Stepan P, Burgess, Christopher, Zhou, Zhi-Wei, He, Zhi-Xu, Zhang, Xue-Ji, Pan, Shu-Ting, Yang, Tian-Xin, Duan, Wei, Qiu, Jia-Xuan, Zhou, Shu-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524457/ https://www.ncbi.nlm.nih.gov/pubmed/26251594 http://dx.doi.org/10.2147/IJN.S82255 |
Ejemplares similares
-
Synthesis and Biological Evaluation of Novel Folic Acid Receptor-Targeted, β-Cyclodextrin-Based Drug Complexes for Cancer Treatment
por: Yin, Juan-Juan, et al.
Publicado: (2013) -
Nongenomic mechanisms of physiological estrogen-mediated dopamine efflux
por: Alyea, Rebecca A, et al.
Publicado: (2009) -
Cooperation of Genomic and Rapid Nongenomic Actions of Estrogens in Synaptic Plasticity
por: Lai, Yu-Jie, et al.
Publicado: (2016) -
Rapid nongenomic estrogen signaling controls alcohol drinking behavior
por: Zallar, L.J., et al.
Publicado: (2023) -
Nongenomic effects of estrogens on signal transduction pathways in estrogen-sensitive carcinoma cell lines
por: Djahansouzi, S, et al.
Publicado: (2001)